Drug Development and Delivery

Mission Bio, the leader in single-cell multiomics, published research in Molecular Therapy Advances showing that its Tapestri® platform can profile vector copy number (VCN), surface protein expression, and vector integrity across roughly 10,000 individual CAR-T cells in a single assay. The advance arrives as the FDA tightens expectations around VCN reporting, exposin...

Ecolab Life Sciences is expanding the bioprocessing business with the launch of a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, giving biopharmaceutical manufacturers across Asia better local access to downstream process development support. Strategically located to serve customers throughout the region, the site is Ecolab’s first bioprocessing facility in Asia...

Achieve Life Sciences, Inc.recently announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at...

PCI Pharma Services – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced it has entered into a 10-year commercial supply agreement with Cabaletta Bio Inc. (Nasdaq: CABA) for the automated manufacture of rese-cel (resecabtagene autoleucel), Cabaletta’s investigational CAR T cell therapy for autoimmune diseases. The agreement secures the long-term manuf...